Tendai Kwaramba, MD. MSc. (@kwarambat90) 's Twitter Profile
Tendai Kwaramba, MD. MSc.

@kwarambat90

Hematology/Oncology fellow | Yale Cancer Center.
Global Health enthusiast.
@YaleHemOnc @dukeghi

ID: 1550959837789437952

calendar_today23-07-2022 21:43:46

121 Tweet

160 Followers

180 Following

Yale Hematology Oncology Fellows (@yalehemonc) 's Twitter Profile Photo

Dr. Taylor has an incredible poster on "Impact of a Novel Oral Medication Delivery Device on Patient Engagement and Discontinuation in Individuals Receiving Oral Oncolytic Medications" at #ASCO2025. Fabulous work!

Dr. Taylor has an incredible poster on "Impact of a Novel Oral Medication Delivery Device on Patient Engagement and Discontinuation in Individuals Receiving Oral Oncolytic Medications" at #ASCO2025. Fabulous work!
Yale Hematology Oncology Fellows (@yalehemonc) 's Twitter Profile Photo

Dr. Wang is a constant vibe! Presenting on "Use of Targeted Therapy in Patients with Advanced Non-small Cell Lung Cancer in Response to Broad Genomic Profiling" at #ASCO25. A vibe I say!

Dr. Wang is a constant vibe! Presenting on "Use of Targeted Therapy in Patients with Advanced Non-small Cell Lung Cancer in Response to Broad Genomic Profiling" at #ASCO25. A vibe I say!
Yale Hematology Oncology Fellows (@yalehemonc) 's Twitter Profile Photo

Dr. Nassar is at it again. Presenting on "Association of ctDNA VAF with Outcomes on Matched Targeted Therapies in Advanced Non-small Cell Lung Cancer" at #ASCO25. What a legend!

Dr. Nassar is at it again. Presenting on "Association of ctDNA VAF with Outcomes on Matched Targeted Therapies in Advanced Non-small Cell Lung Cancer" at #ASCO25. What a legend!
Yale Hematology Oncology Fellows (@yalehemonc) 's Twitter Profile Photo

Look at the engagement by Dr. Nie presenting on "Clinical features associated with exceptional response to immunotherapy in patients with non- small cell lung cancer" at #ASCO25. What a star!

Look at the engagement by Dr. Nie presenting on "Clinical features associated with exceptional response to immunotherapy in patients with non- small cell lung cancer" at #ASCO25. What a star!
Yale Hematology Oncology Fellows (@yalehemonc) 's Twitter Profile Photo

Dr. Yasin brilliantly presented on "Comparison of MET Genomic Alterations Identified in Colorectal Cancer vs Gastric Cancer" this morning at #ASCO25. A GI oncology rockstar right here! Faiza Yasin, MD MHS

Dr. Yasin brilliantly presented on "Comparison of MET Genomic Alterations Identified in Colorectal Cancer vs Gastric Cancer" this morning at #ASCO25. A GI oncology rockstar right here! <a href="/faizayasin_md/">Faiza Yasin, MD MHS</a>
Yale Hematology Oncology Fellows (@yalehemonc) 's Twitter Profile Photo

#ASCO2025 gives us the excuse to catch up with former chiefs, Dr. Fanucci and Dr. Ansari who are now in Boston and Kansas City respectively. They are so fabulous, you have no idea!

#ASCO2025 gives us the excuse to catch up with former chiefs, Dr. Fanucci and Dr. Ansari who are now in Boston and Kansas City respectively. They are so fabulous, you have no idea!
Yale Hematology Oncology Fellows (@yalehemonc) 's Twitter Profile Photo

Dr. Perry's oral presentation on "Perturbational single-cell RNA sequencing of patient tumors in Merkel cell and small cell lung carcinoma" at #ASCO25 was FA-BU-LOUS! Curt, you're awe-inspiring! Curt Perry Yunan Nie Tendai Kwaramba, MD. MSc.

Dr. Perry's oral presentation on "Perturbational single-cell RNA sequencing of patient tumors in Merkel cell and small cell lung carcinoma" at #ASCO25 was FA-BU-LOUS! Curt, you're awe-inspiring! <a href="/curtperrymdphd/">Curt Perry</a> <a href="/ynie_md/">Yunan Nie</a> <a href="/KwarambaT90/">Tendai Kwaramba, MD. MSc.</a>
Yale Cancer Center (@yalecancer) 's Twitter Profile Photo

On National #CancerSurvivorsDay, Tendai Kwaramba, MD. MSc. presents new research outlining the risk of second primary cancers in long-term cancer survivors to help guide survivorship care and surveillance. #ASCO25 Yale Hematology Oncology Fellows Smilow Cancer Hospital OncoAlert meetings.asco.org/abstracts-pres…

On National #CancerSurvivorsDay, <a href="/KwarambaT90/">Tendai Kwaramba, MD. MSc.</a> presents new research outlining the risk of second primary cancers in long-term cancer survivors to help guide survivorship care and surveillance. #ASCO25 <a href="/YaleHemOnc/">Yale Hematology Oncology Fellows</a> <a href="/SmilowCancer/">Smilow Cancer Hospital</a> <a href="/OncoAlert/">OncoAlert</a> 

meetings.asco.org/abstracts-pres…
Yale Hematology Oncology Fellows (@yalehemonc) 's Twitter Profile Photo

This morning Dr. Casasanta was commanding her audience presenting on "TP53 genomic alterations including targetable TP53 Y220C mutation in clinically advanced breast cancer" at #ASCO25. Former fellow and now breast attending Dr. Du is clearly impressed. Incredible job Nicole!

This morning Dr. Casasanta was commanding her audience presenting on "TP53 genomic alterations including targetable TP53 Y220C mutation in clinically advanced breast cancer" at #ASCO25. Former fellow and now breast attending Dr. Du is clearly impressed. Incredible job Nicole!
Yale Hematology Oncology Fellows (@yalehemonc) 's Twitter Profile Photo

Dr. Yochum will always impress! He presented this morning on "Assessment of time- to- treatment- failure (TTF) as a surrogate endpoint for overall survival (OS) to immune checkpoint inhibitor (ICI) regimens in metastatic RCC: Findings from an IMDC analysis" at #ASCO25. In awe.

Dr. Yochum will always impress! He presented this morning on "Assessment of time- to- treatment- failure (TTF) as a surrogate endpoint for overall survival (OS) to immune checkpoint inhibitor (ICI) regimens in metastatic RCC: Findings from an IMDC analysis" at #ASCO25. In awe.
Yale Hematology Oncology Fellows (@yalehemonc) 's Twitter Profile Photo

Look at this legend, literally juggling two posters at the same time on "A Phase II Study of Olaparib in IDH1 and IDH2 Mutant Chondrosarcomas and Other Solid tumors" and "A Phase 2 Study of Olaparib and Ceralasertib in IDH mutant Solid Tumors" at #ASCO25. Dr. Costa, a legend.

Look at this legend, literally juggling two posters at the same time on "A Phase II Study of Olaparib in IDH1 and IDH2 Mutant Chondrosarcomas and Other Solid tumors" and "A Phase 2 Study of Olaparib and Ceralasertib in IDH mutant Solid Tumors" at #ASCO25. Dr. Costa, a legend.
Yale Hematology Oncology Fellows (@yalehemonc) 's Twitter Profile Photo

What an incredible opportunity the Dixwell Community House provided chief Tendai Kwaramba, MD. MSc. to participate in the "Walk with a Doc" event as part of the Men's Health Expo and walk. Between encouraging cancer screening, mental health and learning about the community, it was a gift.

What an incredible opportunity the Dixwell Community House provided chief <a href="/KwarambaT90/">Tendai Kwaramba, MD. MSc.</a> to participate in the "Walk with a Doc" event as part of the Men's Health Expo and walk. Between encouraging cancer screening, mental health and learning about the community, it was a gift.
Yale Hematology Oncology Fellows (@yalehemonc) 's Twitter Profile Photo

The first year fellows are almost here, and we are so thrilled. Welcome! We were feeling incomplete without you. And congratulations to our senior fellows on finishing the year strong. The future of hematology and oncology is oh so bright! ✨️

The first year fellows are almost here, and we are so thrilled. Welcome! We were feeling incomplete without you. And congratulations to our senior fellows on finishing the year strong. The future of hematology and oncology is oh so bright! ✨️
Yale Hematology Oncology Fellows (@yalehemonc) 's Twitter Profile Photo

Congratulations to the graduates, class of 2025! You were brilliant. You were kind. You were compelling. You were inspiring. And as you go off to different parts of the country, on new and bold adventures, know that we are so proud! And know that this will always be home. 👏🏾👏🏼💙

Congratulations to the graduates, class of 2025! You were brilliant. You were kind. You were compelling. You were inspiring. And as you go off to different parts of the country, on new and bold adventures, know that we are so proud! And know that this will always be home. 👏🏾👏🏼💙